According to the SEC Form 4 filings, DALE MICHAEL D, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $2,668,137 | 2 | 100 |
| 2025-12-10 | Sale | AxoGen, Inc. AXGN | Chief Executive Officer | 25,000 0.0533% | $30.00 | $750,000 | +30.79% | |
| 2025-12-09 | Sale | AxoGen, Inc. AXGN | Chief Executive Officer | 61,463 0.1364% | $31.21 | $1.92M | +27.44% | |
| 2023-03-01 | Sale | Abbott Laboratories ABT | SENIOR VICE PRESIDENT | 1,209 <0.0001% | $100.70 | $121,746 | +5.18% | |
| 2022-03-08 | Sale | Abbott Laboratories ABT | SENIOR VICE PRESIDENT | 4,000 0.0002% | $117.00 | $468,001 | -5.61% | |
| 2022-03-01 | Sale | Abbott Laboratories ABT | SENIOR VICE PRESIDENT | 1,053 <0.0001% | $118.15 | $124,412 | -7.02% | |
| 2021-07-28 | Sale | Abbott Laboratories ABT | SENIOR VICE PRESIDENT | 17,600 0.001% | $120.33 | $2.12M | +1.33% | |
| 2021-03-01 | Sale | Abbott Laboratories ABT | SENIOR VICE PRESIDENT | 1,475 <0.0001% | $120.61 | $177,900 | +0.26% | |
| 2020-03-02 | Sale | Abbott Laboratories ABT | Senior Vice President | 787 <0.0001% | $77.89 | $61,299 | +27.25% | |
| 2020-02-19 | Sale | Abbott Laboratories ABT | Senior Vice President | 396 <0.0001% | $88.97 | $35,232 | +14.65% |